Medication Description: Mildronat (Mildronatum)
MILDRONAT (Mildronatum). 3- (2, 2, 2-trimethylhydrazinium) propionate; monohydrate.
Synonym: Trimethylhydrazinium propionate
White crystalline powder with a faint odor. Easily soluble in water, it is difficult - in alcohol. Hygroscopic.
Mildronate is a quaternary ammonium compound. It has a partial structural similarity with carnitine.
The drug improves metabolic processes, increases efficiency.
It is proposed for use in adults in order to increase endurance to physical exertion, reduce the phenomena of physical and mental overstrain, accelerate the rehabilitation of patients in the postoperative period. There is evidence of an improvement in the use of mildronate for the well-being of patients with coronary heart disease complicated by heart failure, and on the prevention of the onset of ventricular arrhythmias.
Assign mildronat inside (30 minutes after eating), as well as intravenously. For therapeutic purposes, Mildronate is ingested 0.25 g 2 to 4 times a day. 5 ml of a 10% solution (0.5 mg) is injected into a vein once a day. The course of treatment 10 14 (20) days. If necessary, repeat it after a 2–3 week break.
To prepare for particularly intense physical exertion, mildronate is prescribed according to special schemes.
Form release: capsules (yellow-red) 0.25 g per pack of 10 capsules; 10% solution in ampoules of 5 ml (0.5 g) in a package of 5 ampoules.
Storage: List B. Capsules - in a dry place, ampoules - at a temperature not higher than + 5 'C.